4.31k followers • 30 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks have the highest aggregate Environmental, Social and Governance scores as rated by Sustainalytics Research. This list is generated daily and limited to the top 30 stocks that meet the criteria.
Wells Fargo & Company
Coca-Cola FEMSA, S.A.B. de C.V.
National Grid plc
Digital Realty Trust, Inc.
First Republic Bank
Stanley Black & Decker, Inc. CORP UNIT 2017
Concho Resources Inc.
Teva Pharmaceutical Industries Limited
InterContinental Hotels Group PLC
Bausch Health Companies Inc.
Continental Resources, Inc.
Grupo Aval Acciones y Valores S.A.
Mobile TeleSystems Public Joint Stock Company
Kimco Realty Corporation
CF Industries Holdings, Inc.
Xerox Holdings Corporation
Sociedad Quimica y Minera de Chile S.A.
Zions Bancorporation, National Association
Cabot Oil & Gas Corporation
LATAM Airlines Group S.A.
New York Community Bancorp, Inc.
WPX Energy, Inc.
Cimarex Energy Co.
Bob Doll, chief equity strategist at Chicago fund manager Nuveen, says markets are priced for good news. But he also doesn’t expect a recession.
(WFC) is searching for a new wealth and investment management chief after it bumped Jon Weiss to a new position in charge of corporate and investment banking. The changes are part of a major business-line restructuring under relatively new CEO Charles Scharf. Speaking of Wells Fargo, it has ended forced arbitration for employees’ sexual harassment claims.
Wells Fargo & Co.'s Charlotte operations will likely see an influx of technology workers in the coming months.
Shares of real estate investment trusts rallied again Friday, as another drop in Treasury yields helped spark a broad rally in the high-yielding sector. The SPDR Real Estate Select Sector ETF rose 0.8%, with 25 of 31 equity components gaining ground. The ETF (XLRE) was on track for a 7th-straight gain, and 5th-straight record close. The win streak would be the longest since the 7-day up stretch ending Jan. 31, 2019. The REIT sector is viewed by many as a bond proxy, given its relatively stable equity characteristics and high dividend yield. The XLRE's dividend yield is 2.84%, while the yield on the 10-year Treasury note was 1.581%, down 3.6 basis points from Thursday. The 10-year yield has lost 33.8 basis points since the end of 2019, and was approaching the 3-year low of 1.459% hit on Sept. 4, 2019. Meanwhile, the implied yield on the S&P 500 was 1.79%. Among the XLRE's biggest gainers Friday, shares of Digital Realty Trust Inc. rose 3.1%, Public Storage advanced 1.8% and Extra Space Storage Inc. tacked on 1.7%.
Digital Realty's (DLR) Q4 performance reflects solid demand for data-center facilities. The company remains well poised to bank on it through accretive acquisitions and development efforts.
As far as earnings surprises are concerned, Ovintiv (OVV) has an excellent record, having gone past the Zacks Consensus Estimate in each of the last four reports.
Concho Resources' (CXO) two major areas of interest that are output growth and oil price realizations are boosting investors' sentiments on the stock this earnings season.
Cimarex Energy (XEC) fourth-quarter earnings are likely to have been supported by a rise in total production and higher oil price realization.
In Q4, Williams Companies (WMB) is expected to have gained from additional volumes from the expansion projects around its core Transco pipeline system.
Let's see if WestRock Company (WRK) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Angel Buchanan knows how important it is to stand out in a crowded Central Florida banking market. The South Central Florida region bank president for Wells Fargo & Co. is one of two presidents in the market for the area's third-largest bank, with more than $7.47 billion in local deposits, according to Orlando Business Journal research. On the hiring front, Buchanan has targeted the creation of a diverse team, including military veterans, for which she had the second-highest hiring rate across the company.
Restructuring efforts and use of technology to enhance revenues have been the main themes for banks over the last five trading days amid concerns related to impact of Covid-19 virus globally.
Shares of Teva Pharmaceuticals (NYSE:TEVA) were up over 9% in late trading on Feb.12. The company posted EPS and revenue that exceeded analysts' expectations.Source: JHVEPhoto / Shutterstock.com The earnings report made it three quarters in a row that Teva stock has beaten revenue expectations. The bottom line number marked a reversal from the third quarter. In that quarter, the company missed on EPS.The positive earnings report was good news for a company that needs it. But the results already were baked into the stock.InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Company Has Successfully Cut CostsTeva has been facing two significant roadblocks to growth. The first was unwinding a pile of debt the company took on from its $40 billion purchase of Actavis Generics from Allergan (NYSE:AGN) in 2016. The company is still bringing forward about $25 billion in liabilities. * 20 Stocks to Buy From the Law of Accelerating Returns The company is also forecasting a loss of revenue from its top-selling multiple sclerosis drug Copaxone. Teva is forecasting that sales of Copaxone will drop to $1.2 billion from $1.5 billion. To help with that, the company has just completed a $3 billion restructuring.This is helping lower the company's operating costs. But what investors will be keen to monitor is alternate revenue streams. The company is expecting to make up some of the decline in Copaxone revenue with increased sales of Austedo and Ajovy which have begun to pick up. Austedo is a treatment for tardive dyskinesia. Ajovy is a migraine treatment. Teva and the Opioid LawsuitThe second obstacle is a lack of resolution in the company's legal battle that spans five states. Teva is among one of several drugmakers listed in the lawsuit. The suit alleges that Teva (among others) bears responsibility for the expansion of the opioid epidemic that has plagued the United States for several years.Teva's stock briefly went up in October on the announcement that it had offered a settlement. In the settlement offer, Teva agreed to pay $250 million in cash over ten years. The company will also supply $23 million in drugs. The total settlement for all the companies involved would total $48 billion.However, the settlement is not approved by all the attorneys general involved. In October, Teva was optimistic that it would have a resolution by the end of the year. But with the calendar moving deeper into 2020, the settlement is still not approved.Perhaps for legal reasons, the company did not offer any further guidance on a resolution during the conference call. In fairness, there may be a resolution to the lawsuit in short order. However, in an election year, it may drag on for some time. And that means it could still be hanging over the stock for some time. The Trend Is Against Teva StockTeva stock has been trending down since reaching its all-time high in 2015. The bigger problem is that the stock dipped below $20 late in 2018. Since then, it has never regained that level. In fact, the stock topped out at just over $19 in 2019. Currently, it would take a surge of more than 40% for Teva to reach $20.However, the stock has surged over 100% since August. It makes you wonder if there is any more run left in the stock. Even if the stock went up by 20%, Teva would be generating a nice return. But that would put the stock around $16 per share. And Teva stock hasn't been higher than $15 per share since April 2019. To reach that level, the stock would have to rise just over 10% from current levels.If the company can put the lawsuit behind it, it would go a long way to taking away uncertainty, but right now I think Teva has already priced in all its good news.As of this writing, Chris Markoch did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 20 Stocks to Buy From the Law of Accelerating Returns * 10 Strong Lottery Ticket Stocks That Could Soar in 2020 * 7 U.S. Stocks to Buy on Coronavirus Weakness The post Positive Earnings Look as If They're Already Priced in to Teva Stock appeared first on InvestorPlace.
This is the latest in the Series B round of funding for Elliptic, which saw $23 million pouring in earlier in funding led by Japanese banking giant SBI Holdings Inc. (OTC: SBHGF). Elliptic Discovery is a risk management solution for banks that lets them assess the risks associated with their customers trading in cryptocurrencies. Many of the institutions that earlier shied away from cryptocurrencies, either due to regulatory hurdles or due to the financial risks involved, are now looking towards adoption as Facebook Inc.'s (NASDAQ: FB) Libra cryptocurrency project started a storm last year that saw many central banks work on their own centralized version of digital currencies.
Wells Fargo & Co is planning to eliminate about 700 workers in Manila, Philippines, and move a portion of these roles to India that already houses nearly 12,000 tech employees, the U.S. bank's spokesman said on Thursday. The eliminations of the staff was earlier reported by Bloomberg, which also said the lender is telling about 650 of its tech workers in the United States that they will be required to relocate to a bigger market to keep their jobs.
The Coronavirus is just a catalyst for changes in the oil market, which Russia will be able to influence solely by gradually phasing out the OPEC+ deal
Digital Realty Trust (DLR) delivered FFO and revenue surprises of 2.53% and -0.82%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of LATAM Airlines Group S.A (LATAM) EETCs and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) reported fourth-quarter sales and revenues that slightly exceeded estimates but issued a guarded outlook for 2020. The Teva Analysts BofA Securities analyst ...
The Business Journal spoke with Gary Pirri, Wells Fargo market executive for New England commercial banking, about how the middle market is faring in Boston.